The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas/Agensys; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen; Merck; MSD; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas/Agensys; Janssen; Sanofi

Efficacy and safety of nivolumab in renal cell carcinoma patients with BONE metastases: Results of the GETUG: AFU 26 nivoren multicenter phase II study.
 
Maud Velev
No Relationships to Disclose
 
Cécile Dalban
No Relationships to Disclose
 
Christine Chevreau
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Pfizer/Ipsen
 
Gwenaelle Gravis
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); IPSEN (Inst); Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Sanofi/Aventis (Inst)
Speakers' Bureau - Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi/Aventis (Inst)
Research Funding - BMS (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Pfizer; Sanofi
 
Sylvie Negrier
Honoraria - Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer
Research Funding - IPSEN (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; IPSEN; Novartis; Pfizer
 
Brigitte Laguerre
Honoraria - Astellas Pharma; AstraZeneca; Ipsen; Ipsen; Ipsen; Janssen-Cilag; MSD Oncology
Travel, Accommodations, Expenses - Astellas Pharma; Janssen; Janssen Oncology; Novartis; Pfizer; Pfizer; pfizer
 
Marine Gross-Goupil
Consulting or Advisory Role - Amgen; amgen; Astellas Medivation; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); BMS (Inst); ipsen (Inst); Janssen-Cilag (Inst); Merck (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; AstraZeneca; ipsen; ipsen; ipsen; Janssen-Cilag; pfizer; Roche
Other Relationship - Janssen
 
Sylvain Ladoire
Research Funding - Novartis (Inst)
Expert Testimony - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Novartis; Pfizer; Sanofi
 
Victoria Ferrari
No Relationships to Disclose
 
Lionnel Geoffrois
Honoraria - BMS; Ipsen; Merck serono; Pfizer
Consulting or Advisory Role - Ipsen
Travel, Accommodations, Expenses - Ipsen; Janssen Oncology; Merck KGaA; MSD Oncology
 
Hubert Curcio
No Relationships to Disclose
 
Frank Priou
Consulting or Advisory Role - AstraZeneca
 
Quentin Dominique Thomas
No Relationships to Disclose
 
Cécile Mione
No Relationships to Disclose
 
Philippe Barthélémy
Honoraria - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Eisai; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; MSD; Pfizer
 
Florence Tantot
No Relationships to Disclose
 
Bernard Escudier
Honoraria - Bristol-Myers Squibb; Ipsen; Oncorena; Pfizer
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Ipsen; Oncorena; Pfizer
Research Funding - BMS France (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD
 
Sylvie Chabaud
No Relationships to Disclose
 
Laurence Albiges
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Peloton therapeutics (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Constance Thibault
No Relationships to Disclose